We are live on
!
Find out more
Barrow, Hanley, Mewhinney & Strauss Portfolio holdings
AUM
$30.5B
1-Year Est. Return
29.95%
This Fund
S&P 500
This Quarter
Est. Return
+3.22%
1 Year Est. Return
+29.95%
3 Year Est. Return
+81.25%
5 Year Est. Return
+106.98%
10 Year Est. Return
+342.87%
AUM
$65.7B
AUM Growth
+$262M
(+0.4%)
Cap. Flow
-$1.29B
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
26.53%
Holding
362
New
36
Increased
82
Reduced
200
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$713M |
| 2 |
Cardinal Health
CAH
|
+$533M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$358M |
| 4 |
Fidelity National Financial
FNF
|
+$181M |
| 5 |
Elevance Health
ELV
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$518M |
| 2 |
Entergy
ETR
|
+$423M |
| 3 |
Honeywell
HON
|
+$287M |
| 4 |
CenterPoint Energy
CNP
|
+$264M |
| 5 |
Johnson & Johnson
JNJ
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.02% |
| 2 | Healthcare | 19.84% |
| 3 | Industrials | 14.73% |
| 4 | Energy | 11.33% |
| 5 | Technology | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Lifetime Brands
LCUT
$209M
| $559K | ﹤0.01% |
38,360
+21,095
| +122% | +$329K |
|
|
ATW
302
DELISTED
Atwood Oceanics
ATW
| $547K | ﹤0.01% |
+43,672
| New | +$456K |
|
303
Ennis
EBF
$564M
| $533K | ﹤0.01% |
+27,779
| New | +$527K |
|
304
Tejon Ranch
TRC
$447M
| $528K | ﹤0.01% |
23,015
+12,455
| +118% | +$267K |
|
|
AVX
305
DELISTED
AVX Corporation
AVX
| $514K | ﹤0.01% |
37,852
-94,704
| -71% | -$1.25M |
|
|
IXYS
306
DELISTED
IXYS Corp
IXYS
| $505K | ﹤0.01% |
49,291
+6,090
| +14% | +$66.3K |
|
307
KRONOS Worldwide
KRO
$989M
| $495K | ﹤0.01% |
94,325
-211,482
| -69% | -$1.27M |
|
|
AEGN
308
DELISTED
Aegion Corp
AEGN
| $489K | ﹤0.01% |
+25,097
| New | +$502K |
|
309
Boise Cascade
BCC
$2.96B
| $465K | ﹤0.01% |
20,281
-34,820
| -63% | -$761K |
|
310
Travelzoo
TZOO
$77.5M
| $457K | ﹤0.01% |
56,938
-11,276
| -17% | -$89.5K |
|
|
FDML
311
DELISTED
Federal-Mogul Holdings Corporation
FDML
| $451K | ﹤0.01% |
54,259
-174,285
| -76% | -$1.53M |
|
|
WMAR
312
DELISTED
West Marine Inc
WMAR
| $434K | ﹤0.01% |
51,757
+23,263
| +82% | +$214K |
|
313
Virtus Investment Partners
VRTS
$1.11B
| $425K | ﹤0.01% |
5,970
-8,701
| -59% | -$659K |
|
|
RT
314
DELISTED
Ruby Tuesday Georgia
RT
| $406K | ﹤0.01% |
+112,473
| New | +$476K |
|
|
LBY
315
DELISTED
Libbey, Inc.
LBY
| $394K | ﹤0.01% |
24,779
-10,635
| -30% | -$182K |
|
|
GHL
316
DELISTED
Greenhill & Co., Inc.
GHL
| $384K | ﹤0.01% |
23,810
-87,855
| -79% | -$1.74M |
|
317
CACI
CACI
$14.1B
| $347K | ﹤0.01% |
3,835
-265
| -6% | -$26.3K |
|
318
Johnson Outdoors
JOUT
$515M
| $323K | ﹤0.01% |
+12,583
| New | +$302K |
|
|
ZIXI
319
DELISTED
Zix Corporation
ZIXI
| $195K | ﹤0.01% |
+51,996
| New | +$203K |
|
|
PZN
320
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $188K | ﹤0.01% |
24,683
-612
| -2% | -$5.2K |
|
|
RPXC
321
DELISTED
RPX Corporation
RPXC
| $119K | ﹤0.01% |
+13,022
| New | +$131K |
|
322
Modine Manufacturing
MOD
$10.5B
| $116K | ﹤0.01% |
13,171
-111,192
| -89% | -$1.14M |
|
|
CDI
323
DELISTED
CDI Corp.
CDI
| $110K | ﹤0.01% |
18,019
-53,054
| -75% | -$340K |
|
324
ABM Industries
ABM
$2.82B
| – | – |
-44,335
| Closed | -$1.43M |
|
|
BELFB
325
Bel Fuse Inc Class B
BELFB
$4.29B
| – | – |
-21,909
| Closed | -$320K |
|
Similar funds
Barrow, Hanley, Mewhinney & Strauss's Q2 2016 Portfolio in Review
As of Q2 2016, Barrow, Hanley, Mewhinney & Strauss held 362 positions worth $65.7B, up 0.4% from $65.4B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barrow, Hanley, Mewhinney & Strauss's Q2 2016 filing shows 36 new, 82 increased, 200 reduced and 39 closed positions. Its largest new stake was Fidelity National Financial: 7,688,148 shares worth $200M. The largest sale was Medtronic, an estimated $518M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.
- Barrow, Hanley, Mewhinney & Strauss's largest Q2 2016 buy was Fidelity National Financial: 7,688,148 shares worth $200M.
- Barrow, Hanley, Mewhinney & Strauss added most to Teva Pharmaceuticals in Q2 2016, an estimated $713M increase.
- Barrow, Hanley, Mewhinney & Strauss's biggest Q2 2016 reduction was Medtronic, cutting an estimated $518M.
- Barrow, Hanley, Mewhinney & Strauss fully exited People's United Financial Inc in Q2 2016, selling an estimated $180M.
- Barrow, Hanley, Mewhinney & Strauss's ten largest holdings make up 27% of its $65.7B portfolio in Q2 2016.
- Barrow, Hanley, Mewhinney & Strauss opened 36 new positions and closed 39 in Q2 2016.
- Barrow, Hanley, Mewhinney & Strauss's portfolio value rose 0.4% quarter-over-quarter to $65.7B.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2016, filed 8 Aug 2016.